MyndTec (XCNQ:MYTC) Interest Income : C$0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2022. Start your Free Trial

What is MyndTec Interest Income?

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments. MyndTec's interest income for the three months ended in Sep. 2024 was C$0.00 Mil. Its interest income for the trailing twelve months (TTM) ended in Sep. 2024 was C$0.00 Mil.

MyndTec Interest Income Historical Data

The historical data trend for MyndTec's Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MyndTec Interest Income Chart

MyndTec Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Interest Income

0.01

MyndTec Quarterly Data
	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Interest Income	Get a 7-Day Free Trial											-	-	-	-	-

MyndTec Interest Income Calculation

Interest Income is the interest earned on cash temporarily held in savings accounts, certificates of deposits, or other investments.

Interest Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.00 Mil.

MyndTec Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MyndTec Inc (XCNQ:MYTC) » Definitions » Interest Income

Comparable Companies

Traded in Other Exchanges

N/A

Address

1900 Minnesota Court, Suite 122, Mississauga, ON, CAN, L5N 3C9

Website

https://www.myndtec.com

MyndTec Inc is a medical technology company. It researches, develops, and distributes new therapies designed to improve function, maximize independence and enhance the quality of life for individuals with upper limb paralysis due to stroke, spinal cord injury, or traumatic brain injury. The firm develops non-invasive neurological and nervous system electrical stimulation therapeutics for the treatment of neurological diseases and injuries specifically targeted to markets with large, growing, and patient populations. The company generates revenues from sales in Canada and the United States.

MyndTec Headlines

No Headlines